Condition
Spinal Bone Metastases
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Terminated2
Withdrawn1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05808998UnknownPrimary
A Single-center Observational Clinical Trial of Stereotactic Radiotherapy on Metastatic Spinal Tumors Using TomoTherapy
NCT01308489Not ApplicableTerminated
Minimally Invasive Surgery in Treating Patients With Spinal Tumors
NCT01407341Phase 1Terminated
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
NCT01345903Not ApplicableWithdrawn
Robotic-Assisted Surgery in Treating Patients With Spine Tumors
Showing all 4 trials